PSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
PSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
dc.contributor.author | Costa, MGS | |
dc.contributor.author | Santos, M | |
dc.contributor.author | Senna, K | |
dc.date.accessioned | 2024-10-29T17:01:47Z | |
dc.date.available | 2024-10-29T17:01:47Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Costa MGS, Santos M, Senna K. PSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE. VALUE IN HEALTH. 2018 oct;21(S1)eS481. doi: 10.1016/j.jval.2018.09.2600 | |
dc.identifier.other | DOI: 10.1016/j.jval.2018.09.2600 | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/545 | |
dc.language.iso | en | |
dc.publisher | VALUE IN HEALTH | |
dc.title | PSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE | |
dc.type | Article |